AT-96

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAT-96
Drug Alias NameAT-96
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines
Mechanisms of ActionHIV p17 matrix protein inhibitors
TargetsHIV p17 matrix protein
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedestea
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedestea
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A